Overview

Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer

Status:
NOT_YET_RECRUITING
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
Efficacy Study of Digoxin Combined with Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer
Phase:
PHASE1
Details
Lead Sponsor:
Fudan University
Collaborator:
Anyang Tumor Hospital
Treatments:
Digoxin
tislelizumab